etoposide,pembrolizumab
merck
['biomarker', 'etoposide', 'keynote-604', 'pembro', 'sclc']
 unveiling insights from the phase 3 keynote-604 study on pembrolizumab + etoposide for extensive-stage sclc. preliminary results? improved pfs &amp; favorable os ! more to explore on tmb and other biomarkers. stay tuned! #asco23 
🫁Pneumo-Onco🩺 Chef de Pôle de Méd à Orientation Onco 🏥 @CHToulonLaSeyne 🔬Conseil Scientifique @IFCTLung / Pdte du 3C VarOuest 👉🏼#HopitalPublic #LungCancer